The S&P 500 ceded 0.6%, as the benchmark index held above its 50-day moving average. The S&P 500 also snapped a nine-day ...

Vertex Pharmaceuticals (VRTX) and Neurocrine Biosciences (NBIX) shares are moving sharply after their respective earnings ...

Vertex has recorded some 25,000 prescriptions for Journavx since its January approval and is in the process of getting big ...

Announced rosnilimab, a depleter and agonist targeting PD-1+ T cells, achieved positive results in Phase 2b rheumatoid arthritis (RA) trial; to present updated clinical and translational data in the ...

Detailed price information for Boston Scientific Corp (BSX-N) from The Globe and Mail including charting and trades.

BioCryst Pharma's ORLADEYO leads HAE market growth, with strong financial performance and potential despite rising ...

LLY's post-market drop offers investment potential with robust R&D, capex strategies, and strong cash flow, positioning it ...

Deep-pocketed investors have adopted a bearish approach towards Amgen AMGN, and it's something market players shouldn't ...

Derivatives exchange Cboe Global Markets reported a record first-quarter profit on Friday and boosted its annual revenue ...

Looking ahead, revenue is expected to decline by 2.0% p.a. on average during the next 3 years, while revenues in the Pharmaceuticals industry in the US are expected to grow by 8.8%.

Porsche's margins plunged in the first quarter, the sportscar maker said on Tuesday, forcing it to cut its outlook due to ...